FMP
Gelesis Holdings, Inc.
GLS
NYSE
Inactive Equity
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
0.159 USD
0 (0%)
About
ceo
Mr. Yishai Zohar
sector
Healthcare
industry
Biotechnology
website
https://www.gelesis.com
exchange
NYSE
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
CIK
0001805087
ISIN
N/A
CUSIP
36850R204
Address
501 Boylston Street
Phone
617 456 4718
Country
US
Employee
93
IPO Date
Jan 14, 2022
Key Executives
